资讯
For as many as 200 million people around the world affected by peripheral artery disease (PAD), 1 the evolution of endovascular innovations certainly provides a source of optimism. Within 3 decades, ...
Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular ...
Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...
In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...
Microbot Medical Inc., a precommercial-stage medical technology company that is developing the Liberty endovascular robotic system ...
Brainomix announced the FDA clearance of a feature that enables physicians to assess ischemic core volume from universally ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
LeMaitre Vascular, Inc. Glow 'N Tell 55-cm Tape 55 Centimeter markings on flexible radiopaque ruler LeMaitre Vascular, Inc. Glow 'N Tell Tape 30 Centimeter markings on flexible radiopaque ruler ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm-diameter balloon; guidewire-free) Aortic Temporary occlusion of large blood vessels and/or ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Front Line Medical Technologies Inc. COBRA-OS REBOA (large vessel balloon occlusion device; 4-F; 25-mm diameter-balloon; guidewire-free) Distal Intended for temporary occlusion of large vessels ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果